Top rated comment
about 6 years ago
Patients with recurrent acute lymphoblastic leukemia are treated with daunorubicin (40 mg/m2/week X 4), vincristine (1.5 mg/m2/week X 4), and prednisone (40 mg/m2/day x 28).
Other commentsSign in to post comments. You don't have an account? Sign up now!
